Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Retraction notice to "Quercetin modulates expression of serum exosomal long noncoding RNA NEAT1 to regulate the miR-129-5p/BDNF axis and attenuate cognitive impairment in diabetic mice" [Life Sci. 340 (2024) 122449].
Life Sci. 2024 Jun 15;347:122679. doi: 10.1016/j.lfs.2024.122679. Epub 2024 May 1.
Life Sci. 2024.
PMID: 38697877
No abstract available.
Corrigendum: Stylopine: a potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy.
Velayutham NK, Thamaraikani T, Wahab S, Khalid M, Ramachawolran G, Abullais SS, Wong LS, Sekar M, Gan SH, Ebenezer AJ, Ravikumar M, Subramaniyan V, Izzati Mat Rani NN, Wu YS, Jeyabalan S.
Velayutham NK, et al. Among authors: thamaraikani t.
Front Pharmacol. 2024 Jan 17;15:1343756. doi: 10.3389/fphar.2024.1343756. eCollection 2024.
Front Pharmacol. 2024.
PMID: 38299157
Free PMC article.
Item in Clipboard
Quercetin modulates expression of serum exosomal long noncoding RNA NEAT1 to regulate the miR-129-5p/BDNF axis and attenuate cognitive impairment in diabetic mice.
Wang H, Jayasankar N, Thamaraikani T, Viktor P, Mohany M, Al-Rejaie SS, Alammar HK, Anad E, Alhili F, Hussein SF, Amin AH, Lakshmaiya N, Ahsan M, Bahrami A, Akhavan-Sigari R.
Wang H, et al. Among authors: thamaraikani t.
Life Sci. 2024 Mar 1;340:122449. doi: 10.1016/j.lfs.2024.122449. Epub 2024 Jan 20.
Life Sci. 2024.
PMID: 38253310
Retracted.
Item in Clipboard
Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation.
Chehelgerdi M, Chehelgerdi M, Allela OQB, Pecho RDC, Jayasankar N, Rao DP, Thamaraikani T, Vasanthan M, Viktor P, Lakshmaiya N, Saadh MJ, Amajd A, Abo-Zaid MA, Castillo-Acobo RY, Ismail AH, Amin AH, Akhavan-Sigari R.
Chehelgerdi M, et al. Among authors: thamaraikani t.
Mol Cancer. 2023 Oct 9;22(1):169. doi: 10.1186/s12943-023-01865-0.
Mol Cancer. 2023.
PMID: 37814270
Free PMC article.
Review.
Item in Clipboard
Stylopine: A potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy.
Velayutham NK, Thamaraikani T, Wahab S, Khalid M, Ramachawolran G, Abullais SS, Wong LS, Sekar M, Gan SH, Ebenezer AJ, Ravikumar M, Subramaniyan V, Mat Rani NNI, Wu YS, Jeyabalan S.
Velayutham NK, et al. Among authors: thamaraikani t.
Front Pharmacol. 2023 Mar 28;14:1150270. doi: 10.3389/fphar.2023.1150270. eCollection 2023.
Front Pharmacol. 2023.
PMID: 37056983
Free PMC article.
Item in Clipboard
In Silico Docking of Novel Phytoalkaloid Camalexin in the Management of Benomyl Induced Parkinson's Disease and its In Vivo Evaluation by Zebrafish Model.
Thamaraikani T, Karnam M, Velapandian C.
Thamaraikani T, et al.
CNS Neurol Disord Drug Targets. 2022;21(4):343-353. doi: 10.2174/1871527320666210903091447.
CNS Neurol Disord Drug Targets. 2022.
PMID: 34477539
Item in Clipboard
Cite
Cite